Skip to search formSkip to main contentSkip to account menu

MGCD516

Known as: Multitargeted Kinase Inhibitor MGCD516 
An orally bioavailable, receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Upon administration, multitargeted kinase… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Epilepsy is a chronic neurologic disorder that affects over 70 million people worldwide. Despite the availability of over 20… 
Review
2017
2017
2017
Alzheimer’s disease (AD) is a complex, multifactorial disease in which different neuropathological mechanisms are likely involved… 
Review
2015
Review
2015
UNLABELLED The use of high-throughput next-generation sequencing techniques in multiple tumor types during the last few years has… 
Highly Cited
2015
Highly Cited
2015
Sarcomas are rare but highly aggressive mesenchymal tumors with a median survival of 10–18 months for metastatic disease… 
Review
2006
Review
2006
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal cancer of teh gastrointestinal tract. They are… 
Highly Cited
2005
Highly Cited
2005
563 Background: Autocrine and paracrine signaling involving VEGFR and PDGFR are implicated in angiogenesis and proliferation of… 
Highly Cited
2000
Highly Cited
2000
The scheduling of antifolate antitumor agents, including the new multitargeted autofolate LY231514 (MTA), with 5-fluorouracil was…